TrialBritish journal of clinical pharmacology2012

Mechanism-based population pharmacokinetic modelling in diabetes: vildagliptin as a tight binding inhibitor and substrate of dipeptidyl peptidase IV.

Cornelia B Landersdorfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.